Inflammatory bowel disease patients' perspectives of clinical trials: a global quantitative and qualitative analysis
DT Rubin, L Peyrin-Biroulet, W Reinisch… - Crohn's & Colitis …, 2021 - academic.oup.com
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
[HTML][HTML] Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
DT Rubin, L Peyrin-Biroulet, W Reinisch… - Crohn's & Colitis …, 2021 - ncbi.nlm.nih.gov
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
D Rubin, L Peyrin-Biroulet, W Reinisch, S Tole… - Crohn's & Colitis …, 2021 - europepmc.org
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
DT Rubin, L Peyrin-Biroulet, W Reinisch… - … & colitis 360, 2021 - pubmed.ncbi.nlm.nih.gov
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
[PDF][PDF] Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
DT Rubin, L Peyrin-Biroulet, W Reinisch, S Tole… - 2021 - academia.edu
Background: Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
D Rubin, L Peyrin-Biroulet, W Reinisch… - Crohn's & Colitis …, 2021 - hal.univ-lorraine.fr
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.
DT Rubin, L Peyrin-Biroulet, W Reinisch, S Tole… - Crohn's & Colitis …, 2021 - go.gale.com
Background: Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
[PDF][PDF] Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
DT Rubin, L Peyrin-Biroulet, W Reinisch… - Crohn's & Colitis …, 2021 - academic.oup.com
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.
DT Rubin, L Peyrin-Biroulet, W Reinisch, S Tole… - Crohn's & Colitis …, 2021 - europepmc.org
Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …